FDA inspection
Sanofi-Aventis Deutschland GmbH: FDA inspection ending Apr 30, 2012
FDA inspection 788644 · No Action Indicated (NAI) · Frankfurt Am Main
Key facts
| Inspection ID | 788644 |
|---|---|
| Firm | Sanofi-Aventis Deutschland GmbH |
| FEI number | 3003195501 |
| Address | Industriepark Hochst, Bruningstr. 50 |
| City | Frankfurt Am Main |
| Country | Germany |
| Fiscal year | 2012 |
| Inspection end date | Apr 30, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data